HBOT News & Research
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling
Abstract Aim: Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal...
High plasma glutamate levels are associated with poor functional outcome in acute ischemic stroke.
Abstract: The aim of the present study was to investigate the relationship between acute ischemic stroke and glutamate levels and to determine the prognosis value of plasma glutamate levels to predict the functional outcome. Two hundred and...
To debride or not, that is the question.
Abstract: Mutluoglu, Uzun, Karagoz, Memis, Ersen, Ay, , , (2016). To debride or not, that is the question. International wound journal, 2016 Oct;13(5):1038-9. https://www.ncbi.nlm.nih.gov/pubmed/25196036
Unestablished indications for hyperbaric oxygen therapy.
Abstract: Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps...
Unestablished indications for hyperbaric oxygen therapy.
Abstract: Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps...
Unestablished indications for hyperbaric oxygen therapy.
Abstract: Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps...
Primary Cutaneous γδ T-Cell Lymphoma and Hemophagocytic Syndrome.
Abstract: Primary cutaneous γδ T-cell lymphoma and hemophagocytic syndrome (HPS) is a very rare disease process with only 41 cases of this type of lymphoma published to date. We report the case of a 56-year-old woman who developed high-grade fevers...
Primary Cutaneous γδ T-Cell Lymphoma and Hemophagocytic Syndrome.
Abstract: Primary cutaneous γδ T-cell lymphoma and hemophagocytic syndrome (HPS) is a very rare disease process with only 41 cases of this type of lymphoma published to date. We report the case of a 56-year-old woman who developed high-grade fevers...
Selective spleen tyrosine kinase inhibition delays autoimmune arthritis in mice.
Abstract: Spleen tyrosine kinase (SYK) has an important role in immunoreceptor signaling, and SYK inhibition has accordingly attenuated immune-mediated injury in several models. Therefore, the present study examined the effect of SYK inhibition...